Patent Listing Review Should Be FDA Function, Rep. DeLauro Suggests

FDA should review patents before they are listed in the "Orange Book," members of the House Agriculture Appropriations Subcommittee suggested March 21

Pink Sheet Podcast

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".

More from Archive

More from Pink Sheet